Orgenesis, Inc. (ORGS)
0.4124
+0.38
(+1161.16%)
USD |
OTCM |
Sep 08, 16:00
Orgenesis Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2024 | -0.4869 |
| September 30, 2024 | -0.7238 |
| June 30, 2024 | -0.8402 |
| March 31, 2024 | -1.004 |
| December 31, 2023 | -1.078 |
| September 30, 2023 | -1.415 |
| June 30, 2023 | -1.622 |
| March 31, 2023 | 2.590 |
| December 31, 2022 | 0.7355 |
| September 30, 2022 | 0.9499 |
| June 30, 2022 | 0.6396 |
| March 31, 2022 | 0.342 |
| December 31, 2021 | 0.3076 |
| September 30, 2021 | 0.2984 |
| June 30, 2021 | 0.2476 |
| March 31, 2021 | 0.2356 |
| December 31, 2020 | 0.2455 |
| September 30, 2020 | 0.1379 |
| June 30, 2020 | 0.1286 |
| March 31, 2020 | 0.1335 |
| December 31, 2019 | 2.513 |
| September 30, 2019 | 1.966 |
| June 30, 2019 | 1.296 |
| March 31, 2019 | 0.8547 |
| November 30, 2018 | 0.1314 |
| Date | Value |
|---|---|
| August 31, 2018 | 0.0952 |
| May 31, 2018 | 0.1099 |
| February 28, 2018 | 0.2323 |
| November 30, 2017 | 0.5446 |
| August 31, 2017 | 0.7116 |
| May 31, 2017 | 0.774 |
| February 28, 2017 | 1.830 |
| November 30, 2016 | 0.9303 |
| August 31, 2016 | 0.6424 |
| May 31, 2016 | 0.5037 |
| February 29, 2016 | 0.4523 |
| November 30, 2015 | 0.6844 |
| August 31, 2015 | -5.300 |
| May 31, 2015 | 0.565 |
| February 28, 2015 | -0.6965 |
| November 30, 2014 | -0.8228 |
| August 31, 2014 | -0.6414 |
| May 31, 2014 | 0.00 |
| February 28, 2014 | -0.2182 |
| November 30, 2013 | -0.1298 |
| August 31, 2013 | -0.1977 |
| May 31, 2013 | -0.245 |
| February 28, 2013 | 0.00 |
| November 30, 2012 | 0.00 |
| August 31, 2012 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Agenus, Inc. | -1.458 |
| Amgen, Inc. | 4.903 |
| Anika Therapeutics, Inc. | 0.1839 |
| BioCryst Pharmaceuticals, Inc. | -1.842 |
| Imunon, Inc. | 1.873 |